Physician profile
David B Bybee
NPI 1548238108
$1,016.47
in general payments reported to CMS, 2019-2025
14 companies · $55.29 in 2025
The $55.29 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $258 · 2021: $67.22 · 2022: $167 · 2023: $80.56 · 2024: $159 · 2025: $55.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $284.99 | 2019-2023 | Codman Hakim, Codman Certas, Cusa Clarity |
| Spinal Elements, INC. | $171.86 | 2020-2024 | |
| Medtronic, INC. | $149.18 | 2024-2025 | Catalyft Pl Expandable Interbody System, Mazor X System |
| Stryker Corporation | $75.29 | 2019-2023 | Universal Neuro 3 |
| Boston Scientific Corporation | $69.95 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Baxter Healthcare | $53.88 | 2022 | |
| Osteomed LLC | $43.60 | 2020 | |
| Aesculap, INC. | $34.18 | 2019-2021 | |
| Depuy Synthes Sales INC. | $33.59 | 2020 | |
| Saluda Medical Americas, INC. | $29.89 | 2025 | Evoke |
| Bk Medical Holding Company INC. | $27.07 | 2023 | Bk3000, Bk3500 & Bk5000 Ultrasound System |
| Nevro Corp. | $18.38 | 2019 | |
| Relievant Medsystems, INC. | $14.11 | 2021 | |
| Cerapedics INC. | $10.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bybee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.